Clinical Trials Sponsored by Mora sjukhus

Total 300 results

Okyo Pharma Ltd
ORA, Inc.

Completed

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

Dry Eye Disease

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia (CLARITY)

Eye Diseases | Refractive Error | Presbyopia | Miosis | Near Vision

United States
Bausch & Lomb Incorporated
ORA, Inc.

Completed

A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle

Allergic Conjunctivitis

United States
Faes Farma, S.A.
ORA, Inc.

Completed

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

Allergic Conjunctivitis

United States
Allgenesis Biotherapeutics Inc.
ORA, Inc.

Completed

A Study of AG-80308 in Dry Eye Patients

Dry Eye Disease

United States
BRIM Biotechnology Inc.
ORA, Inc.

Completed

Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

Dry Eye Syndrome

United States
Bausch & Lomb Incorporated
ORA, Inc.

Completed

Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness

Hyperemia

United States
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Chronic Allergic Conjunctivitis
Rhodes Pharmaceuticals, L.P.
ORA, Inc.

Completed

Safety and Efficacy of PG101 for Dry Eye Syndrome (PG101)

Dry Eye Syndrome

United States
D'Albis Dental
University of Bari Aldo Moro

Completed

Periodontal Health and Its Relationship With Psychological Stress

Periodontal Diseases | Stress | Mucositis | Periodontal

Italy
Thomas More Kempen
Revalidatie & MS Centrum Overpelt

Unknown

Assessing Fatiguability of Tongue Muscles in MS

Multiple Sclerosis | Fatigue | Muscle Weakness | Deglutition Disorders | Exertion; Excess

Belgium
ORA, Inc.
Stuart Therapeutics, Inc.

Recruiting

Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)

Dry Eye Disease

United States
Neuracle Genetics, Inc
ORA, Inc.

Recruiting

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Age-Related Macular Degeneration

Canada
2C Tech Corp
ORA, Inc.

Not yet recruiting

Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM)

Retinitis Pigmentosa
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Phase 3 Safety Study for the Treatment of Presbyopia Subjects

Eye Diseases | Presbyopia | Miosis | Near Vision

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia (CLARITY)

Eye Diseases | Presbyopia | Miosis | Near Vision

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

Eye Diseases | Refractive Errors | Presbyopia | Ophthalmic Solutions | Brimonidine Tartrate | Aceclidine

United States
Faes Farma, S.A.
ORA, Inc.

Completed

A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model

Allergic Conjunctivitis

United States
Aldeyra Therapeutics, Inc.
ORA, Inc.

Completed

A Study of ADX-102 in Subjects With Allergic Conjunctivitis

Conjunctivitis, Allergic

United States
ORA, Inc.
Palatin Technologies, Inc

Completed

Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye

Dry Eye Disease

United States
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Chronic Allergic Conjunctivitis
Bausch & Lomb Incorporated
ORA, Inc.

Completed

Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants

Hyperemia

United States
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Chronic Allergic Conjunctivitis
Nicox Ophthalmics, Inc.
ORA, Inc.

Completed

A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution

Healthy Subjects

United States
3E Therapeutics Corporation
ORA, Inc.

Completed

Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis

Seasonal Allergic Rhinitis
Herantis Pharma Plc.
ORA, Inc.

Completed

Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye

Dry Eye Syndrome

United States
Eye Therapies, LLC
ORA, Inc.

Completed

A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)

Allergic Conjunctivitis

United States
Universiti Teknologi Mara
Universiti Sains Islam Malaysia

Not yet recruiting

Nutrition and Physical Activity Intervention on Psychosocial Well-Being of Postpartum Mothers

Postpartum Depression | Lifestyle, Healthy

Malaysia
Universiti Teknologi Mara
Ministry of Education, Malaysia

Not yet recruiting

Study Protocol of the EMPOWER-SUSTAIN Project

Metabolic Syndrome
Francisco Javier Navarro Moya
Andaluz Health Service

Unknown

Efficacy of a Didactic Intervention in Anticoagulated Patients (TAOPE Study) (TAOPE)

Health Education | Blood Coagulation Tests | Patient Education as Topic

Spain
Mona Frolova

Unknown

Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer

Esophageal Neoplasms | Squamous Cell Carcinoma | Concurrent Chemoradiotherapy

Russian Federation
Stuart Therapeutics, Inc.
ORA, Inc.

Completed

Study of ST-100 as Treatment for Dry Eye Disease

Dry Eye Disease

United States
ORA, Inc.
Topivert Pharma Ltd

Completed

Safety and Efficacy of TOP1630 for Dry Eye Syndrome

Dry Eye Syndrome

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia

Eye Diseases | Refractive Errors | Presbyopia

United States
ORA, Inc.
Tufts Medical Center

Completed

Food Allergy Challenge Diagnostic Study

Food Hypersensitivity

United States
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye

Dry Eye
Woodmont Pharmaceuticals, Inc.
ORA, Inc.

Terminated

Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections

Allergic Rhinitis | Allergic Conjunctivitis

United States
Bausch & Lomb Incorporated
ORA, Inc.

Completed

Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.

Hyperemia

United States
Deacon Biosciences, Inc.
ORA, Inc.

Completed

A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers

Ocular Infection

United States
nora mostafa mohammed abo shanady

Completed

Evaluation of Apexogenesis With Human Treated Dentin Matrix in Young Permanent Molars

Dentin Bridge

Egypt
University of Minnesota
Sanofi; Moran, Antoinette, M.D.

Completed

Insulin Glargine Vs Standard Insulin Therapy

Cystic Fibrosis Related Diabetes

United States
Universiti Teknologi Mara
Ministry of Higher Education Malaysia

Not yet recruiting

Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health (TRES)

Myocardial Infarction

Malaysia
Lieven De Maesschalck
Handicap International

Completed

3D-printing and Acces to Tele Rehabilitation (Imp&acte3D)

Orthopedic Disorder

Mali, Niger, Togo
Je Bouge Pour Mon Moral
University Grenoble Alps

Completed

Physical Exercise and Depressive Symptoms in Moderately or Severely Depressed Adults (EXIMOS)

Depressive Symptoms

France
Think Surgical Inc.
MCRA; Medical Metrics Diagnostics, Inc

Completed

TSolution One® Total Knee Arthroplasty

Osteoarthritis, Knee

United States
José Joaquín Mira

Recruiting

Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer

Prostate Cancer | Prostate Cancer Diagnosis

Spain
More Foundation
ElMindA Ltd; Riddell, LLC; Mimic Systems

Unknown

Longitudinal Brain Health in Youth Tackle Football Players

Athletic Injuries | Concussion, Brain

United States
Moira Taylor
King Abdulaziz University

Not yet recruiting

The Combined Effect of Dietary Nitrate and Caloric Restriction on Cognitive and Vascular Function. (CRNitrateMRI)

Healthy | Overweight and Obesity | Older Adults

United Kingdom
Oslo University Hospital
Helse More and Romsdal Trust

Active, not recruiting

Kinematics of Contemporary Knee Arthroplasty

Knee Osteoarthritis

Norway
Paradigm Spine
MCRA; MDT Medical Device Testing GmbH

Completed

Clinical Trial Comparing Decompression With and Without Coflex™ Interlaminar Technology Treating Lumbar Spinal Stenosis

Spinal Stenosis

Germany

Clinical Trials Sponsored by Mora sjukhus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations